OTC PINK:MDCE - Medical Care Technologies Unveils Game-Changing AI Mental Health Breakthrough
Rhea-AI Summary
Medical Care Technologies (OTC PINK:MDCE) has unveiled an AI-powered Facial Micro-Expression Mental Health Scanner that can detect early signs of emotional and psychological distress through short selfie videos. The technology combines facial coding with affective computing to identify subtle emotional biomarkers that may indicate conditions like depression, anxiety, or PTSD before visible symptoms appear.
The innovation targets the global mental health tech market, projected to exceed $60 billion by 2030. The company plans to integrate this technology across multiple platforms including telehealth, university counseling centers, and wearable devices, aiming to provide scalable, stigma-free mental health screening solutions.
Positive
- Innovation in AI-powered mental health screening technology targeting a $60B market by 2030
- Non-invasive, scalable solution accessible through smartphones and connected devices
- Multiple integration pathways across telehealth, education, and consumer platforms
- Potential for early detection and improved mental health outcomes
Negative
- Early-stage technology without proven clinical validation
- Operating in highly competitive AI healthcare space
- No mention of regulatory approvals or clinical trials
- Potential privacy concerns with facial recognition technology
AI-Powered Emotion Scanner Aims to Revolutionize Mental Health Screening Across Telehealth, Education & Consumer Platforms
MESA, ARIZONA / ACCESS Newswire / July 15, 2025 / Medical Care Technologies Inc. (OTC PINK:MDCE), a health-tech innovator pushing the boundaries of AI-powered diagnostics, today announces a major advancement in its digital health portfolio: an AI Facial Micro-Expression Mental Health Scanner designed to detect early emotional and psychological distress using nothing more than a short selfie video.
This next-gen technology merges facial coding with affective computing, decoding subtle micro-expressions that often precede visible symptoms of depression, anxiety, or PTSD. By identifying these emotional biomarkers before patients even recognize the signs themselves, MDCE is laying the groundwork for real-time, scalable, preventive mental health screening.
"This technology has the potential to redefine how mental health is approached globally," said a company spokesperson. "With integration pathways ranging from telehealth to university counseling centers to wearable platforms, we are targeting a market that is not only underserved, but urgently in need of scalable, stigma-free solutions."
The global mental health tech market is projected to exceed
This initiative is part of MDCE's expanding R&D focus, alongside its subsidiaries:
Infinite Auctions (www.infiniteauctions.com), a leader in investment-grade memorabilia auctions
Real Game Used (www.realgameused.com), a disruptor in AI photo-match authentication and sports-tech solutions
To learn more about the scanner or opportunities for early-stage collaboration, visit www.medicalcaretechnologies.com.
About Medical Care Technologies Inc. (OTC Pink: MDCE)
Medical Care Technologies Inc. is a forward-focused health tech company developing AI-based self-screening tools to empower users through early detection. With growing interest in AI diagnostic platforms, MDCE is developing solutions for wound care, dermatological monitoring, and mental health, targeting large and underserved markets.
Safe Harbor Statement
This press release contains forward-looking statements, including expectations for future product development and market impact. These statements involve risks and uncertainties. Actual results may differ. The company assumes no obligation to update these statements.
Company Info:
Medical Care Technologies Inc (OTC PINK:MDCE)
www.medicalcaretechnologies.com
Investor & Media Contact:
Infinite Auctions / MDCE
info@infiniteauctions.com
SOURCE: Medical Care Technologies Inc.
View the original press release on ACCESS Newswire